Ms Karen Katen
| Ms Karen Katen enhances our Board’s understanding of international, supply chain and marketing matters, with her expertise in those areas gained through her career at Pfizer Inc, a global pharmaceutical company. Ms Katen began her career at Pfizer in 1974 and held a series of management positions with increasing responsibility, including President of Pfizer Global Pharmaceuticals and Executive Vice President of Pfizer Inc from 2001 to 2005 and President of Pfizer Human Health from 2005 to 2007. She retired in March 2007 as Vice Chairman of Pfizer Inc Recently, she also served as Chairman of the Pfizer Foundation, a charitable foundation affiliated with Pfizer. Currently, Ms Katen serves as Senior Advisor of Essex Woodlands Health Ventures, a healthcare venture capital firm which she joined in October 2007. Ms Katen is also a director of Air Liquide since 2008, an international leader in gases for industry, health and the environment. Ms Katen has served with several healthcare-related organizations, including as a member of the Global Advisory Board of Takeda Pharmaceutical Company Limited, Treasurer of PhRMA, an industry association representing research-based pharmaceutical companies in the U.S., a board member of the National Alliance for Hispanic Health, a member of the Healthcare Leadership Council, and a member of the RAND Corporation’s Health Board of Advisors. She is also on the Board of Trustees of the Economic Club of New York and the University of Chicago and is a council member of the Booth Graduate School of Business at the University of Chicago. Ms Katen has also served on a variety of international policy bodies, including as Chairman of the U.S.-Japan Business Council. |
Mr Jean-Yves Gilles
| Mr Jean-Yves Gilles is Senior Vice President, John Deere Power Systems, John Deere Intelligent Solutions Group, and Advanced Technology and Engineering, a position he’s held since June 2009. Gilles is also responsible for Global Supply Management and Logistics. Gilles joined John Deere in 1980 as an engineer at the John Deere Harvester Works. He served in a variety of positions of increasing responsibility at John Deere Usine Saran, John Deere Werke Mannheim, John Deere Waterloo Works and John Deere Zweibrücken. In 1998, he was named as Director, Region II Manufacturing, and in 2001, he was appointed Senior Vice President, Manufacturing and Engineering for global harvesting equipment. Gilles was named Senior Vice President, John Deere Power Systems in 2005. Gilles has a master's degree in mechanical engineering from Ecole Centrale de Paris and a master's degree in business administration from Stanford University. Mr Jean-Yves Gilles is Director of Orange SA. |
Mr Dominique Reiniche
| Mrs. Dominique Reiniche is a graduate of the Essec. In 1978, she joined Procter & Gamble and in 1983 became Associate Advertising Manager. In 1986, she joined Kraft Jacobs Suchard and was apppointed Marketing & Strategy Manager. In 1992, she joined Coca-Cola Entreprise as a Marketing & Responsible Compte-cle Manager. In 1998, she was appointed Chairman and Chief Executive Officer of Coca-Cola Entreprise andVice-Chairman of Coca Cola Enterprises - Europe Group in 2002. From January 2003 to May 2005, she was Chairman of Coca-Cola Enterprises - Groupe Europe. Since May 2005, Mrs. Dominique Reiniche is Chairman Europe of the Coca- Cola Company. |
Ms Betsy Atkins
| Ms. Betsy S. Atkins has served as Chief Executive Officer of Baja Ventures, a technology, life sciences and renewable energy early stage venture capital fund, since 1994. She served as the Chairman and Chief Executive Officer of Clear Standards, Inc., which developed enterprise level emission measurement software, from 2008 to 2009 until its sale to SAP. She previously served as Chairperson and Chief Executive Officer of NCI, Inc., a neutraceutical functional food company, from 1991 through 1993. Ms. Atkins co-founded Ascend Communications, a manufacturer of communications equipment, in 1989, where she was also a member of the board of directors until its acquisition by Lucent Technologies, a telecommunications systems, software and products company, in 1999. Ms. Atkins currently serves on the board of directors of Polycom, Inc., Chico’s FAS, Inc., and Schneider Electric, Inc. She is a member of the Council on Foreign Relations. Ms. Atkins served on the boards of directors of Vonage Holdings Corp. from 2005 to 2007; Reynolds American, Inc. from 2004 to 2010; and Towers Watson & Co. in 2010. She served as a presidential appointee to the Pension Benefit Guaranty Corp. board of directors from 2001 to 2003. Ms. Atkins is also a member of Florida International University’s College of Medicine Health Care Network Faculty Group Practice, Inc. |
Mr Denis Duverne
| Mr. Denis Duverne is a graduate of the Ecole des Hautes Etudes Commerciales (HEC). After graduating from the Ecole Nationale d'Administration (ENA), he started his career in 1984 as commercial counselor for the French Consulate General in New York before becoming Director of the Corporate Taxes Department for the French Ministry of Finance in 1986. In 1988, he became Deputy Assistant Secretary for Tax Policy for the French Ministry of Finance and, in 1991, he was appointed Corporate Secretary of Compagnie Financiere IBI. In 1992, hebecame a member of the Executive Committee of Banque Colbert, in charge of operations. In 1995, Mr. Denis Duverne joined the AXA Group and assumed responsibility for supervision of AXA's operations in the US and the UK and managed the reorganization of AXA companies in Belgium and the United Kingdom. Since February 2003, Mr. Denis Duverne has been a member of the AXA Management Board, in charge of Finance, Control and Strategy. |
Mr Henri De Castries
| Mr. Henri de Castries is a graduate of the Ecole des Hautes Etudes Commerciales (HEC) and obtained a law degree before completing preparatory studies for the Ecole Nationale d'Administration (ENA). After graduating from ENA, Henri de Castries began his career with the French Finance Ministry Inspection Office. Mr. de Castries joined AXA's corporate finance department on September 1,1989. He was appointedCorporate Secretary in 1991 and was appointed Senior Executive Vice-President for the Group's asset management, financial and real-estate businesses in 1993. In 1997, Mr. de Castries was appointed Chairman of The Equitable Companies Incorporated (now AXA Financial). Mr. de Castries has been Chairman of the AXA Management Board since May of 2000. |
Mr Philippe Luscan
| Philippe Luscan is a graduate of the École Polytechnique and the École des Mines in Biotechnology in Paris. He began his career in 1987 as a Production Manager at Danone. In 1990, he joined the Group as Director of the Sanofi Chimie plant at Sisteron, France, and subsequently served as Industrial Director of Sanofi in the United States, as Vice President Supply Chain and as Vice President Chemistry in September 2006. He was appointed to his present position in September 2008. |
Mr Christopher Viehbacher
| Christopher Viehbacher, Chief Executive Officer and Director. Other current directorships and appointments - Chairman of the Executive Committee and the Management Committee of sanofi-aventis, Member of the Strategy Committee of sanofi-aventis, Chairman of the Board of Directors of PhRMA (United States), Vice Chairman of EFPIA (Belgium), Member of the Board of Directors of Research America (United States) and Burroughs Wellcome Fund (United States), Member of the Board of Visitors of Fuqua School of Business, Duke University (United States), Member of the Board of Business Roundtable (United States). Education and business experience - Graduate in Commerce of Queens University (Ontario-Canada); certified public accountant, Began his career at PricewaterhouseCoopers Audit. 1998-2008 - Various positions at the GSK group, including President Pharmaceutical Operations for North America. Past directorships held since 2006 - Director of GlaxoSmithkline plc until November 2008 (United Kingdom), Member of the Board of Triangle United Way (United States, 2003-2008), of Cardinal Club (United States, 2004-2008) and GlaxoSmithKline NC Foundation (United States, 2003-2008), Vice Chairman of Portfolio Management Board of GSK plc (United Kingdom, 2007-2008), Member of Advisory Council of Center for Healthcare Transformation (United States, until 2010). Date of Birth - March 26, 1960, Nationalities - German and Canadian. Christopher Viehbacher is a citizen of Germany and Canada. |
Mr Roberto Pucci
| Roberto Pucci has a law degree from the University of Lausanne, Switzerland. He started his career in 1985 at Coopers & Lybrand in Geneva, Switzerland as an external auditor. He then joined Hewlett-Packard (HP) in 1987, where he held various positions in Human Resources in Switzerland and Italy including HR Manager for the European Headquarters and Human Resources Director in Italy. In 1999, he became Director, Compensation & Benefits for Agilent Technologies, a spin off from HP, and was appointed Vice President Human Resources Europe in 2003. In 2005 he moved to the United States to join Case New Holland, a subsidiary of the Fiat Group, as Senior Vice President, Human Resources, and was appointed, in 2007, Executive Vice President, Human Resources for the Fiat Group in Torino, Italy. Roberto Pucci joined Sanofi as Senior Vice President Human Resources in October 2009. Roberto Pucci is a citizen of Italy and Switzerland. |
Mr Jerome Contamine
| Jérôme Contamine is a Graduate of École Polytechnique (X), ENSAE, and ENA (Ecole Nationale d'Administration). After four years at the Cour des Comptes, as a Senior State General Auditor, he joined Elf Aquitaine in 1988, as advisor to the Chief Financial Officer, and became Group Finance and Treasury Director in 1991. He became the General Manager of Elf Petroleum Norway in 1995, after being named Deputy Vice President of Elf Upstream Division for Europe and the U.S. In 1999, he was appointed as a member of the taskforce for integration with Total, in charge of the reorganization of the merged entity, TotalFinaElf, and in 2000 became Vice President Europe and Central Asia, Upstream Division of Total. The same year, he joined Veolia Environnement as CFO and Deputy General Manager. In 2003, he was appointed Vice-President Senior Executive, Deputy Chief Executive Officer, Financial Director of Veolia Environnement. Jérôme Contamine joined Sanofi as Executive Vice President, Chief Financial Officer (CFO) of Sanofi in March 2009. |
Mr Serge Weinberg
| Mr Serge Weinberg is Chairman of the Appointments and Governance Committee and of the Strategy Committee of Sanofi* Chairman of Weinberg Capital Partners, Financière Piasa and Piasa Holding, Director of VL Holding, Manager of Alret and Maremma, Member of the Supervisory Board of Financière BFSA, Vice Chairman and Director of Financière Poinsétia and Financière Sasa, Member of the Supervisory Board of Schneider Electric* Weinberg Capital Partners' representative on the Board of Alliance Industrie and Sasa Industrie, Chairman of Corum (Suisse). Education and business experience, Graduate in law Degree from the Institut d'Etudes Politiques, Studies at the ENA (Ecole Nationale d'Administration) 1976-1982 Sous-Préfet and then Chief of Staff of the French Budget Minister (1981) 1982-1987 Deputy General Manager of FR3 (the French Television Channel) and then Chief Executive Officer of Havas Tourisme 1987-1990 Chief Executive Officer of Pallas Finance 1990-2005 Various positions at PPR* group including Chairman of the Management Board for 10 years.Past directorships held since 2007, Chairman of the Board of Accor* (2006-2009) Director of Alliance Industrie (2006-2008), of Road Holding (2007-2008) and of Rasec (2006-2010) Member of the Board of Pharma Omnium International (2006-2010) Member of the Supervisory Board of Rothschild & Cie (until 2010) Member of the Supervisory Board of Gucci Group (Netherlands, until 2010) Director of Fnac (until 2010) and of Rothschild Concordia (until 2010) Vice Chairman of the Supervisory Board of Schneider Electric* (until 2010) Director of Team Partners Group (until 2011) Member of the Supervisory Board Amplitude Group and Alfina (until 2011). |
Mr Lindsay Owen-Jones
| Lindsay Owen-Jones, Director. Other current directorships and appointments - Member of the Compensation Committee, of the Appointments and Governance Committee and of the Strategy Committee of sanofi-aventis, Chairman of the Board of Directors of L’Oréal, Chairman of the Strategy and Implementation Committee of L’Oréal, Chairman of the Board of Directors of Fondation d’Entreprise L’Oréal (Foundation), Chairman of Alba Plus, L’Oréal UK Ltd (United Kingdom) and L’Oréal USA Inc. (United States), Director of Ferrari S.p.A. (Italy), Education and business experience - Bachelor of Arts (Hons) from Oxford University and degree from INSEAD, Since 1969 - Various positions at the L’Oréal group, including Chairman and Chief Executive Officer (1988-2006) and Chairman of the Board of Directors since April 25, 2006, 1989-2005 - Director of BNP Paribas. Past directorships held since 2006 - Chief Executive of L’Oréal (1988-2006), Vice-President and member of the Supervisory Board of L’Air Liquide (2001-2006), Vice-Chairman of the Board of Directors of L’Air Liquide (2006-2009), Director of Galderma Pharma until 2006. Date of Birth - March 17, 1946. Nationality - British. |
Mr Klaus Pohle
| Mr Klaus Pohle is Independent Director and Chairman of the Audit Committee of sanofi-aventis, Director of Labelux Group GmbH (Switzerland), Director and Chairman of the Audit Committee of Coty Inc., New York, (United States), Professor of business administration at Berlin Institute of Technology (Germany). Education and business experience - Doctorate in law from Frankfurt University (Germany), Doctorate in economics from Berlin University (Germany), Masters in law from Harvard University, Professor of Business Administration at the Berlin Institute of Technology, 1966-1980 - Various positions at the BASF group, 1981-2003 - Deputy Chief Executive Officer and Chief Financial Officer of Schering AG, 2003-2005 - Chairman of the German Accounting Standards Board. Past directorships held since 2006 - President of the Supervisory Board (in 2008) and Vice-President of the Supervisory Board of Hypo Real Estate Holding AG, Munich (Germany), Member of the Supervisory Board of DWs investment GmbH (Germany, prior to 2005-2009).date of Birth - November 3, 1937. Nationality - German. |
Mr Robert Castaigne
| Mr Robert Castaigne is independent Director of Sanofi since 2000, and serves as Chairman of the Audit Committee sin. Other current directorships and appointments - Member of the Audit Committee of sanofi-aventis, Independent Non-Executive Director at VINCI SA since 2007, Société Générale and Compagnie Nationale à Portefeuille (Belgium), Member of the Audit Committee of Compagnie Nationale à Portefeuille (Belgium), Member of the Audit, Internal control and Risk Committee of Société Générale, Member of the Financial Statements Committee of Vinci. Education and business experience - Degree from the Ecole Centrale de Lille and the Ecole Nationale Supérieure du Pétrole et des Moteurs, Doctorate in economic sciences, 1972-2008 - Various positions at the Total Group, including Chief Financial Officer and member of the Executive Committee (June 1994 - May 2008). Past directorships held since 2006 - Chairman and Chief Executive Officer of Total Chimie (1996-2008) and of Total Nucléaire (1992-2008), Director of Elf Aquitaine (2000-2008), of Hutchinson (1995-2008), of Total Gestion Filiales (1994-2008), of Omnium Insurance & Reinsurance Company Ltd (Bermuda, 1996-2008), of Petrofina (Belgium, 1999-2008), of Total Upstream UK Ltd (United-Kingdom, 2005-2008), Total Gabon (2003-2008), of Arkema (2000-2006) and of Alphega (Bermuda, 2000-2006). Date of Birth - April 27, 1946. Nationality - French. |
Mr Gerard Van Kemmel
| Mr Gerard Van Kemmel is Independent Director and Chairman of the Compensation Committee, Member of the Audit Committee and the Appointments and Governance Committee of sanofi-aventis, Director of Europacorp, Member of the Audit Committee of Europacorp. Education and business experience - Graduate of the Ecole des Hautes Etudes Commerciales (HEC), MBA degree from the Stanford Business School, 1966-1995 - Various positions including President of Arthur Andersen and Andersen Consulting in France (1976-1995) and Chairman of the Board of Arthur Andersen Worldwide (1989-1994), 1996-1997 -Advisor, French Finance Minister, 1997-2006 - Various positions at Cambridge Technology Partners (Chief Operating Officer) and at Novell (Chairman EMEA). Past directorships held since 2006, Europe Chairman of Novell (United States, 2004-2006), Director of Groupe Eurotunnel, Director of Eurotunnel NRS Holders Company Limited (United Kingdom, until 2010). |
Mr Christian Mulliez
| Mr Christian Mulliez is Directorat Sanofi SA. He also serves as Vice President, General Manager Administration and Finance of L'Oréal, Chairman of the Board of Directors of Regefi, Director of DG 17 Invest, L'Oréal USA Inc., The Body Shop International (United Kingdom) and Galderma Pharma (Switzerland). Education and business experience - Degree from the Ecole Supérieure des Sciences Economiques et Commerciales (ESSEC). 1984-2002 - Various positions at Synthélabo and then at Sanofi-Synthélabo, including Vice President Finance. Since 2003 - Executive Vice President Administration and Finance L'Oréal. Date of birth - November 10, 1960. Nationality - French. 1984-2002 Various positions at Synthélabo and then at Sanofi-Synthélabo, including Vice President Finance, Since 2003 Executive Vice President Administration and Finance at L'Oréal. |
Mr Olivier Charmeil
| Olivier Charmeil is a graduate of HEC (Ecole des Hautes Etudes Commerciales) and of the Institut d'Etudes Politiques in Paris. From 1989 to 1994, he worked in the Mergers & Acquisitions department of Banque de l'Union Européenne. He joined Sanofi Pharma in 1994 as head of Business Development. Subsequently, he held various posts within the Group, including Chief Financial Officer (Asia) for Sanofi-Synthélabo in 1999 and Attaché to the Chairman, Jean-François Dehecq, in 2000, before being appointed as Vice President, Development within the Sanofi-Synthélabo International Operations Directorate, where he was responsible for China and support functions. In 2003, Olivier Charmeil was appointed Chairman and Chief Executive Officer of Sanofi-Synthélabo France, before taking the post of Senior Vice President, Business Management and Support within the Pharmaceutical Operations Directorate. In this role, he piloted the operational integration of Sanofi-Synthélabo and Aventis. He was appointed Senior Vice President Asia/Pacific, Pharmaceutical Operations in February 2006 and since January 1, 2008, Operations Japan have reported to him as well as Asia/Pacific and Japan Vaccines since February 2009. Since January 1, 2011, Olivier Charmeil has served as Senior Vice President Vaccines and a member of the Executive Committee. |
Mr Helle Kristoffersen
| Mr Helle Kristoffersen was appointed Director of Strategy and Economic Intelligence of the Total group in January 2012, having been Deputy Director from January to December 2011. From 1994 onwards, she mainly worked for the Alcatel group (now Alcatel Lucent). After holding a number of positions within this group, she was Vice-President, Group Strategy between 2005 and 2008, and Senior Vice-President, Vertical Markets, between January 2009 and December 2010. Helle Kristoffersen is a graduate of the Ecole Normale Superieure and Ecole Nationale Superieure de lElectronique et de ses Applications (ENSAE). She is a Knight of the French Legion of Honor. Born in Denmark, Helle Kristoffersen is a French national. Positions currently held: Director of Strategy and Economic Intelligence of the Total group, Director of France Telecom, Director of Valeo. Positions no longer held (but held in the last five years): Deputy Director of Strategy and Economic Intelligence of the Total group, Vice-President, Strategy of the Alcatel-Lucent group, Senior Vice-President, Vertical Markets of the Alcatel-Lucent group. Mr Helle Kristoffersen is Independent Director of Orange SA. |
Mr Charles-Henri Filippi
| Mr Charles-Henri Filippi is Chairman of Citigroup France since January 1, 2011. He joined Credit Commercial de France (CCF) in 1987 after several years in French government service and in ministerial offices. He became Chief Executive Officer of CCF France in 1998, and was then appointed to the Senior Management of HSBC in 2001, in charge of the groups Corporate and Institutional Banking business. He became Chairman and Chief Executive Officer of HSBC France in March 2004, then Non-Executive Chairman from August 2007 to December 31, 2008. He was also Senior Advisor at CVC Capital Partners France until December 31, 2010 and a Partner at Weinberg Capital Partners until December 31, 2011. He is also founder of asset management companies Octagones and Alfina and was their Chairman from 2008-2012. Charles-Henri Filippi is a French national. Positions currently held: Chairman of Citigroup France, Director of France Telecom*, member of the Audit Committee, Director of LOreal, Director of PIASA, Director of ADIE, Member of the Supervisory Board of EURIS, Member of the Supervisory Board of Femu Qui, Non-voting member of Nexitys Board. Positions no longer held (but held in the last five years): Partner at Weinberg Capital Partners, Senior Advisor of CVC Capital Partners France, Chairman of HSBC France, Chairman of the HSBC Private Bank France Supervisory Board, Director of HSBC Asset Management Holding, Director of HSBC Bank plc, Director of HSBC Private Banking Holdings Switzerland, Director of HSBC Trinkaus & Burkhardt AG, Chairman of Octagones SAS (until May 2012), Chairman of Alfina SAS (until May 2012), Member of the Supervisory Board of Viveris REIM (until July 2012), Director of the Centre National dArt et de Culture Georges Pompidou (until February 2013). Mr Charles-Henri Filippi is Independent Director of Orange SA. |
Mr Daniel Guillot
| Mr Daniel Guillot is Director of Relations with the Ain departement local authority, at the Lyon Regional Division. He joined France Telecom in 1977 as telecommunications and postal controller. In 1986, Daniel Guillot became an Attache at the Ministry of Telecommunications, Postal Services and Space, before becoming Chief Inspector in 1993. He held labor union responsibilities at the CFDT Culture Consulting Communication Federation since its foundation in 2005 as head of management staff and international affairs and finally, since 2007, as central labor representative in charge of the France Telecom-Orange Group. Until 2009, Daniel Guillot had a seat on the worldwide union UNI Telecoms global Committee and chaired the European Telecommunications Social Dialogue Committee jointly with the employer representative. Daniel Guillot is IFA certified. He is a French national. Positions currently held: Director of Relations with the Ain departement local authority for France Telecom-Orange, Director of France Telecom, member of the Audit Committee. Mr Daniel Guillot is Director of Orange SA. |